liver cancer
Conditions
Interventions
Control Group:Conventional Western medicine plus chemotherapy treatment
Research Group:Control group treatment plus modified Xiao Chai Hu Tang treatment
Sponsors
Hengshui City People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria of traditional Chinese and Western medicine as mentioned above; 2. Ascites severity is moderate or higher; 3. Expected survival period = 3 months; 4. Age between 18 and 75 years old; 5. Patient and family members have been informed and have signed the written informed consent form; 6. No history of allergy to Xiao Chai Hu Tang (Minor Bupleurum Decoction) or the study medication.
Exclusion criteria
Exclusion criteria: 1. Patients with other primary malignant tumors or severe dysfunction of major organs such as heart, kidney, or lung; 2. Pregnant or breastfeeding women; 3. Patients with ascites caused by non-primary liver cancer factors such as cirrhosis or tuberculous peritonitis; 4. Patients with mental illness or unable to cooperate with treatment and follow-up; 5. Patients who have received other traditional Chinese medicine, herbal interventions, or targeted therapy within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AST;ALT; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cancer efficacy;ascites volume;EORTC QLQ-C30 Questionnaire;TCM Syndrome Score;AFP;CA125; | — |
Countries
China
Contacts
Public ContactZhao Chunhua
Hengshui City People's Hospital
Outcome results
None listed